Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial

Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial

Annual vaccination is the most effective way to prevent seasonal influenza. Influenza vaccines in multi-dose vial (MDV) formats can facilitate timely vaccination of large populations by reducing per-dose costs and cold storage requirements compared to single-dose pre-filled syringe (PFS) formats. MD...

Full description

Bibliographic Details
Main Authors: Joyce Ojeda, José Luis Arredondo, Perla Salcedo, Mercedes Paredes-Paredes, Martin Dupuy, Celine Petit, Anne Laure Chabanon, Enrique Rivas, Sanjay Gurunathan, Iris De Bruijn, Stephanie Pepin
Format: Article
Language:English
Published: Taylor & Francis Group 2020-06-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
quadrivalent influenza vaccines
immunogenicity
safety
influenza
vaccination
children
adolescents
Online Access:http://dx.doi.org/10.1080/21645515.2019.1697595

Internet

http://dx.doi.org/10.1080/21645515.2019.1697595

Similar Items